Hemogenyx Pharmaceuticals PLC Net Asset Momentum

Latest YoY growth as of December 2024: -69.3%

Hemogenyx Pharmaceuticals PLC net asset momentum. Hemogenyx Pharmaceuticals PLC (HEMO) recorded a net asset momentum of -69.3% as of December 2024, with net assets of GBX853.49K GBX. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore HEMO capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

YoY Momentum

-69.3%
Year-over-year

Current Net Assets

GBX853.49K
GBX · December 2024

Years of Data

10
2015 – 2024

Country

UK
LSE

Net Asset Momentum of Hemogenyx Pharmaceuticals PLC (2015–2024)

Net asset momentum of Hemogenyx Pharmaceuticals PLC from 2015 to 2024. This chart tracks Hemogenyx Pharmaceuticals PLC's year-over-year net asset growth across 10 annual reporting periods from 2015 to 2024. The most recent momentum reading is -69.3%, with net assets of GBX853.49K GBX as of December 2024. See shareholders equity of Hemogenyx Pharmaceuticals PLC for net asset value and shareholders' equity analysis.

Hemogenyx Pharmaceuticals PLC Net Asset Momentum by Year (2015–2024)

Hemogenyx Pharmaceuticals PLC net asset momentum by year from 2015 to 2024. The table below shows the complete annual net asset history for Hemogenyx Pharmaceuticals PLC from 2015 to 2024, covering 10 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see HEMO company net worth.

Year Net Assets (GBX) Total Assets Total Liabilities YoY Momentum
2024 GBX853.49K GBX4.21 Million GBX3.36 Million ▼ -69.3%
2023 GBX2.78 Million GBX6.11 Million GBX3.32 Million ▼ -14.3%
2022 GBX3.24 Million GBX7.09 Million GBX3.85 Million ▼ -60.3%
2021 GBX8.17 Million GBX8.52 Million GBX352.84K ▲ +832.7%
2020 GBX875.68K GBX2.66 Million GBX1.79 Million ▲ +350.9%
2019 GBX-349.04K GBX1.05 Million GBX1.40 Million ▼ -136.4%
2018 GBX959.17K GBX2.30 Million GBX1.34 Million ▼ -55.0%
2017 GBX2.13 Million GBX2.40 Million GBX263.69K ▲ +135.9%
2016 GBX903.71K GBX1.05 Million GBX143.69K ▲ +1061.3%
2015 GBX77.82K GBX324.65K GBX246.83K —